| Database ID | Agent | Target | Cancer Type | Detail |
| DB00286 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00287 | IMO2055 | Tolllike receptor 9 | head and neck cancer | view |
| DB00288 | Cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00289 | Cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00290 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | advanced solid tumors | view |
| DB00291 | Cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00292 | Cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00293 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | colorectal cancer | view |
| DB00294 | pimasertib | MEK2 protein kinase
Dual specificity mitogenactivated protein kinase kinase 1 | colorectal cancer | view |
| DB00295 | ramucirumab | Vascular endothelial growth factor receptor 2 | colorectal cancer | view |
| DB00296 | regorafenib | Protooncogene tyrosineprotein kinase receptor ret
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Vascular endothelial growth factor receptor 3 | colorectal cancer | view |
| DB00297 | ganitumab | Insulinlike growth factor I receptor | pancreatic cancer | view |
| DB00298 | buparlisib(BKM120), trametinib | NA | advanced solid tumors | view |
| DB00299 | abituzumab | Integrin alphaV | colorectal cancer | view |
| DB00300 | erlotinib | Epidermal growth factor receptor | pancreatic cancer | view |